Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma-Reference-Cited by-同舟云学术

Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma

Published:2021-09-01 Issue:10 Volume:44 Page:526-532
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Nooijen Lynn E.,Franken Lotte C.,Belkouz Ali,Oulad Abdennabi Ikrame,Besselink Marc G.,Busch Olivier R.,Swijnenburg Rutger-Jan,Klümpen Heinz-Josef,Erdmann Joris I.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference25 articles.

1. Cholangiocarcinoma: epidemiology and risk factors;Khan;Liver Int,2019

2. Cholangiocarcinoma—evolving concepts and therapeutic strategies;Rizvi;Nat Rev Clin Oncol,2018

3. Surgery for cholangiocarcinoma;Cillo;Liver Int,2019

4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

5. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center;Roos;HPB (Oxford),2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives;Updates in Surgery;2024-08-29

2. Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma;HPB;2024-07

3. WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma;HPB;2024-04

4. National consensus on a new resectability classification for perihilar cholangiocarcinoma - A modified Delphi method;European Journal of Surgical Oncology;2023-10

5. Cisplatin/gemcitabine;Reactions Weekly;2023-06-03